Zyomyx, Axon to Develop Scanning Tool for Protein Biochips | GenomeWeb

NEW YORK, April 12 - Zyomyx and Axon Instruments have agreed to jointly develop scanning instrumentation for acquiring and analyzing data from Zyomyx's protein biochips, the companies said Thursday.

Zyomyx, which has said it plans to release a beta version of its chip later this year, will work with Axon to build several generations of scanning products and evaluate fluorescence and non-fluorescence platforms. The companies did not disclose financial details.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.